The Great Lakes Genomics Conference

2017 Program

Home
2018 Registration
2018 Program
2018 Call for Presentations
Our Sponsors
Meetings Calendar
Proceedings of The GLCC
Photo Album 2000-2004
Photo Album 2005-2007
Photo Album 2008-2010
Photo Album 2011-
Links
Dr. H. Allen Gardner Memorial Lecture and Fund

click here to download the GLCC 2017 Newsletter.

Register here for the GLCC 2017!

ANNOUNCING

The Fifty-fifth Annual Great Lakes Cytogenomics Conference

DATES: May 18-19, 2017

LOCATION: 89 Chestnut Street, University of Toronto

ACCOMMODATION: Conference rates are not available at the Metropolitan Hotel or at the University of Toronto Residences. Please make your reservations early!

Doubletree by Hilton:
108 Chestnut Street, Toronto
Telephone: 1 (800) 668-6600 or 1 (416) 599-0555
Room Rate: $229.00

University of Toronto
Residences:
89 Chestnut Street, Toronto
Telephone: 1 (416) 977-0707; press 0
Room Rate ~ $109.00 single or double plus taxes (basic accommodation no TV/no room service; full breakfast buffet included)

GLCC REGISTRATION FEES

1. Advance registration (by April 14, 2017)
Regular: $150 (CDN or USD) One Day: $100 (CDN or USD)
Student: $70 (CDN or USD) One Day: $40 (CDN or USD)

2. Late registration (After April 14, 2017)
Regular: $200 (CDN or USD) One Day: $150 (CDN or USD)
Student: $100 (CDN or USD) One Day: $70 (CDN or USD)

PLEASE NOTE THAT PAYMENT MUST ACCOMPANY ALL REGISTRATIONS. IF PAYMENT IS NOT RECEIVED BY APRIL 14, THE LATE REGISTRATION FEE WILL APPLY AT THE DESK UPON CHECK-IN.

A continental breakfast and lunch for both days of the meeting, as well as a wine and cheese after Thursday's sessions, are included in the registration fee.

Online registration now available at the link below:

HIGHLIGHTS OF THE 2017 GREAT LAKES CYTOGENOMICS CONFERENCE

Here is a sampling of topics this year:

Abdul Noor, Director Genetics Diagnostics, Division of Diagnostic Medical Genetics, Dept. of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario
- Mosaic aneuploidies in preimplantation genetic screening (PGS)

Andrea Vaags, Cytogenomicist, Genetics Laboratory, Trillium Health Partners, Mississauga, Ontario
- Circulating tumour DNA (ctDNA) detection in liquid biopsies

Jean McGowan-Jordan, Head, Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario, Chair of the Standing Committee of the International System for Human Cytogenomic Nomenclature
- Nomenclature matters: update on ISCN 2016

Rene Quevedo, Princess Margaret Cancer Centre, University Health Network, Dept. of Medical Biophysics, University of Toronto, Toronto, Ontario
- Near-global copy-neutral loss of heterozygosity is a defining feature of pancreatic neuroendocrine tumours

Tammy Ashfield, Consultant Technologist, Genetics, Institute for Quality Management in Healthcare, Toronto, Ontario
- The practice patterns of prenatal testing in Canadian Cytogenetic laboratories; IQMH survey results

Adam Shlien, Associate Director, Translational Genetics, DPLM, Scientist, Genetics and Genome Biology, SickKids, Toronto, Ontario
- KiCS: translational cancer genomics in kids

Melanie Beaulieu Bergeron, Associate Head, Children's Hospital of Eastern Ontario Genetics Diagnostic Laboratory, Ottawa, Ontario
- Update on iAMP21: what's up, Doc?

Marsha Speevak, Cytogenomicist and Discipline Lead, Molecular Genetics and Cytogenetics, Trillium Health Partners, Mississauga, Ontario
- Group presentation on interesting cases or lab-related problems

Maksym Misyura, Advanced Molecular Diagnostic Laboratory, Genome Diagnostics, University Health Network, Toronto, Ontario
- Standards and guidelines for the interpretation and reporting of somatic variants in cancer

Lieve Page-Christiaens, Associate Medical Director, Illumina, Utrecht, The Netherlands
- Non-invasive prenatal whole genome sequencing

The H. Allen Gardner Memorial Lecturer:
Dr. Christa Lese Martin, PhD, FACMG
Director and Senior Investigator
Autism & Developmental Medicine Institute
Geisinger Health System
Lewisburg, PA

Exploring the frequency and phenotypic spectrum of recurrent CNVs in 50,000 individuals